New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IN8bio, Inc.
INAB
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

20M

Biotechnology

Next Earning date - 13 Mar 2025

20M

Biotechnology

Next Earning date - 13 Mar 2025

0.27USD

Shape0.01 ( 3.88%)
Market Closed (as of Feb 10, 21:00 EDT)
favorite-chart

Relative Strenght

6
favorite-chart

Volume Buzz

-25%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated February 11, 2025
1W -5.86 % 1M -14.79 % 3M -22.81 % 1Y -77.49 %

Key Metrics

Shape
  • Market Cap

    19.58M


  • Shares Outstanding

    72.48M


  • Share in Float

    57.73M


  • Dividende

    0


  • Earning Date

    13 Mar 2025


  • Price Target

    0.2701


  • Average Volume

    678265


  • Beta

    -0.069


  • Range

    0.217-1.74


  • Industry

    Biotechnology


  • Website

    https://in8bio.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

INAB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$9M

ShapeNaN%

2025-Revenue

$0.28

Shape-83%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2022-08-30

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.32
vs -0.21

Q1.23

arrow
arrow

N/A

-0.30
vs -0.33

Q2.23

arrow
arrow

N/A

-0.27
vs -0.38

Q3.23

arrow
arrow

N/A

-0.23
vs -0.34

Q4.23

arrow
arrow

N/A

-0.21
vs -0.32

Q1.24

arrow
arrow

N/A

-0.20
vs -0.30

Q2.24

arrow
arrow

N/A

-0.19
vs -0.27

Q3.24

arrow
arrow

N/A

-0.15
vs -0.23

Q4.24

arrow
arrow

N/A

-0.07
vs -0.21

Q1.25

arrow
arrow

N/A

-0.07
vs -0.20

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

3.7M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-34%

-0.34
vs -0.25

Q1.23

arrow
arrow

-41%

-0.41
vs -0.34

Q2.23

arrow
arrow

-35%

-0.35
vs -0.41

Q3.23

arrow
arrow

-40%

-0.40
vs -0.35

Q4.23

arrow
arrow

-30%

-0.30
vs -0.40

Q1.24

arrow
arrow

-49%

-0.49
vs -0.30

Q2.24

arrow
arrow

-63%

-0.63
vs -0.49

Q3.24

arrow
arrow

-83%

-0.83
vs -0.63

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

16

16
vs 15

7%

Q1.23

arrow
arrow

16

16
vs 16

NA

Q2.23

arrow
arrow

21

21
vs 16

31%

Q3.23

arrow
arrow

20

20
vs 21

-5%

Q4.23

arrow
arrow

30

30
vs 20

50%

Q1.24

arrow
arrow

31

31
vs 30

3%

Q2.24

arrow
arrow

25

25
vs 31

-19%

Q3.24

arrow
arrow

25

25
vs 25

NA

Earnings Growth

Latest News